A trio of bipartisan senators want drug maker Mylan to pay back the Department of Defense for overcharging for the allergy drug EpiPen.
The senators said Mylan misclassified the EpiPen that “led the DoD to pay exorbitant rates for the drug at retail pharmacies,” according to a letter sent to Mylan CEO Heather Bresch on Monday. The company has seen outrage from Congress for price hikes for the life-saving drug, which now costs $600 for a two-pack.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.